Merck KGaA

Stamp with blue ink that says FDA Approved
Pharma

Merck KGaA's Pimjetmi wins FDA approval in rare tumor disorder

The FDA's approval was based on phase 3 data in which Pimjetmi demonstrated a 56% response rate and no liver toxicity incidents.
Donavyn Coffey Nov 10, 2026 5:45pm
Lonza

Lonza bets big on US growth, snaps up Merck KGaA’s CDMO business

Nov 3, 2026 9:21am
Four large while puzzle pieces are being connected together on a dark brown table by four sets of hands

Merck KGaA charts biggest deal in 10+ years with Bio-Techne buy

Jun 25, 2026 9:56am
Merck of Germany

Merck KGaA's new CEO Beckmann emphasizes reliance on M&A

May 13, 2026 11:54am
topic report
drug prices biologics drug costs IRA money cash payment co-pay

Top 20 pharma companies by 2025 revenue

Apr 20, 2026 3:00am
topic report
Illustration of multiple orange alarm clocks floating against a blue background scattered at different angles as if suspende

The top 10 drugs losing US exclusivity in 2026

Mar 16, 2026 3:00am